ARCHIVES

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

NIH To Replace RAC With New Committee

July 19, 1996

Without Advance Directives, Families Prolong Treatment

April 27, 2001

In Brief: Fisher, Moore, Metcalf to Share Hammer Prize; NCAB Hearing On Organ Systems Program Dec. 3

October 30, 1987

In Brief: PHS Established Two Scientific Integrity Offices; Workshop On Ethical Issues Planned

August 18, 1989

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976